Tocilizumab in Coronavirus-19 Positive Patients

Clinical trial NCT04423042 · UNKNOWN

Trial details

NCT number: NCT04423042
Sponsor: University of Calgary
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 Coronavirus Inflammation

Start date: 2020-07-30
Primary completion: 2021-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.